Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour
Open Access
- 1 February 2014
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 170 (2) , 321-327
Abstract
Objective: Familial non-medullary thyroid cancer has been proposed as an aggressive clinical entity. Our aim in this study is to investigate potential distinguishing features as well as the biological and clinical aggressiveness of familial vs sporadic papillary thyroid carcinoma (PTC). We assessed clinicopathological characteristics, outcome measures and DNA ploidy.Design: A matched-case comparative study.Methods: A series of patients with familial PTC (n=107) and two subgroups, one with three or more affected elements (n=32) and another including index cases only (n=61), were compared with patients with sporadic PTC (n=107), matched by age, gender, pTNM disease extension and approximate follow-up duration. Histological variant, extrathyroidal extension, vascular invasion, tumour multifocality and bilateral growth were evaluated. Ploidy pattern was analysed in available samples by DNA flow cytometry. The probabilities of disease-free survival (DFS) and overall survival (OS) were estimated according to the Kaplan–Meier (K–M) method.Results: No patient with familial PTC died of disease during follow-up (median, 72 months), contrarily to five patients (4.7%) (P=0.06) with sporadic PTC (median, 90 months). There was a significantly higher tumour multifocality in familial PTC (index cases subgroup) vs sporadic PTC (P=0.035), and a trend, in the familial PTC cohort with three or more affected elements, to show extrathyroidal extension (P=0.054) more frequently. No difference was observed in DNA ploidy status. The K–M analyses showed no significant differences between both entities in relation to DFS or OS.Conclusion: Apart from multifocality, familial PTC appears to have similar clinical/prognostic behaviour when compared with sporadic forms of the disease.Keywords
This publication has 33 references indexed in Scilit:
- SRGAP1Is a Candidate Gene for Papillary Thyroid Carcinoma SusceptibilityThe Journal of Clinical Endocrinology & Metabolism, 2013
- Prevalence, Clinicopathologic Features, and Somatic Genetic Mutation Profile in Familial Versus Sporadic Nonmedullary Thyroid CancerThyroid®, 2011
- DICER1 Mutations in Familial Multinodular Goiter With and Without Ovarian Sertoli-Leydig Cell TumorsJAMA, 2011
- Familial nonmedullary thyroid carcinoma—clinical relevance and prognosis. A European multicenter studyLangenbeck's Archives of Surgery, 2010
- A Germline Mutation (A339V) in Thyroid Transcription Factor-1 (TITF-1/NKX2.1) in Patients With Multinodular Goiter and Papillary Thyroid CarcinomaJNCI: Journal of the National Cancer Institute, 2009
- Mapping a New Familial Thyroid Epithelial Neoplasia Susceptibility Locus to Chromosome 8p23.1-p22 by High-Density Single-Nucleotide Polymorphism Genome-Wide Linkage AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2008
- An Evidence‐based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow‐upWorld Journal of Surgery, 2007
- Localization of a Susceptibility Gene for Familial Nonmedullary Thyroid Carcinoma to Chromosome 2q21The American Journal of Human Genetics, 2001
- Papillary Thyroid Carcinoma Associated with Papillary Renal Neoplasia: Genetic Linkage Analysis of a Distinct Heritable Tumor SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2000
- A Gene Predisposing to Familial Thyroid Tumors with Cell Oxyphilia Maps to Chromosome 19p13.2The American Journal of Human Genetics, 1998